Therma Bright Inc., a company operating within the Health Care sector, specifically in the Health Care Equipment & Supplies industry, has been making strides in the medical technology field. Listed on the TSX Venture Exchange, the company is known for its innovative approach to developing thermal therapeutic devices. These devices are primarily designed for the treatment of insect stings and bites, as well as for the prevention of cold sores.
As of November 1, 2026, Therma Bright Inc. reported a close price of CAD 0.03, which also represents the 52-week low for the company. This figure contrasts with the 52-week high of CAD 0.11, recorded on November 11, 2025. The market capitalization of Therma Bright Inc. stands at CAD 1,340,000, reflecting its current valuation in the market.
The company’s financial metrics indicate a Price Earnings (P/E) ratio of -0.448, suggesting that it is not currently generating profits. This negative P/E ratio is not uncommon for companies in the early stages of development or those investing heavily in research and development, as is often the case in the medical technology sector.
Therma Bright Inc.’s focus on thermal therapeutic devices positions it uniquely in the market. The company’s products aim to provide relief and prevention solutions for common ailments such as insect stings, bites, and cold sores. By leveraging thermal technology, Therma Bright Inc. seeks to offer effective and non-invasive treatment options to consumers.
The company’s strategic direction and product offerings reflect a commitment to addressing specific health care needs through innovative technology. As Therma Bright Inc. continues to develop and refine its products, it remains a noteworthy entity within the health care equipment and supplies industry, particularly for those interested in advancements in thermal therapeutic solutions.
